Evidence map›Paper›PMID 29617409›Full record

ArticlePloS one2018

Microvasculature-directed thrombopoiesis in a 3D in vitro marrow microenvironment.

Surya Kotha, Sijie Sun, Amie Adams, Brian Hayes, Kiet T Phong, Ryan Nagao, Jo-Anna Reems, Dayong Gao, Beverly Torok-Storb, José A López and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Production of plateletsHaematologica · 2025
    Article
  2. Inside-to-outside and back to the future of megakaryopoiesis.Research and practice in thrombosis and haemostasis · 2023
    Article
  3. Review
  4. Microfluidic Biomaterials.Advanced healthcare materials · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Surya KothaDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.ORCID 0000-0003-1385-4630
Sijie SunDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Amie AdamsDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Brian HayesClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Kiet T PhongDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Ryan NagaoDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
Jo-Anna ReemsBloodworks Research Institute, Seattle, Washington, United States of America.
Dayong GaoDepartment of Mechanical Engineering, University of Washington, Seattle, Washington, United States of America.
Beverly Torok-StorbClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
José A LópezBloodworks Research Institute, Seattle, Washington, United States of America.
Ying ZhengDepartment of Bioengineering, University of Washington, Seattle, Washington, United States of America.
University of Washington · USFred Hutch Cancer Center · USBloodworks Northwest · US

Funding

CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HEIMFELD, SHELLY · 1999 to 2014
$14.9M
Stem Cell and Transplantation BiologyU54DK106829 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI DEREK L STIREWALT · 2015 to 2026
$9.1M
Controlling Hematopoietic Lineage Commitment from ESC to PlateletsU01HL099993 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 2009 to 2015
$8.3M
Using iPSCs to model patient outcomes in nephrotic syndromeUH3TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2014 to 2016
$6.1M
Bioengineering Cardiovascular Training GrantT32EB001650 · NIBIB · UNIVERSITY OF WASHINGTON · PI REGNIER, MICHAEL · 2004 to 2019
$3.6M
A Microfluidic Bone Marrow Niche for the Study of HematopoiesisDP2DK102258 · NIDDK · UNIVERSITY OF WASHINGTON · PI ZHENG, YING · 2013 to 2013
$2.6M
A Tissue Engineered Human Kidney Microphysiological SystemUH2TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2012 to 2013
$2.1M
NCATS NIH HHS UH2 TR000504NHLBI NIH HHS U01 HL099993NIBIB NIH HHS T32 EB001650NIDDK NIH HHS DP2 DK102258NIDDK NIH HHS P30 DK056465NIDDK NIH HHS U54 DK106829NIH HHS HL099993NIH HHS UH3 TR000504
6 · The paper itself

Abstract

Vasculature is an interface between the circulation and the hematopoietic tissue providing the means for hundreds of billions of blood cells to enter the circulation every day in a regulated fashion. The precise mechanisms that control the interactions of hematopoietic cells with the vessel wall are largely undefined. Here, we report on the development of an in vitro 3D human marrow vascular microenvironment (VME) to study hematopoietic trafficking and the release of blood cells, specifically platelets. We show that mature megakaryocytes from aspirated marrow as well as megakaryocytes differentiated in culture from CD34+ cells can be embedded in a collagen matrix containing engineered microvessels to create a thrombopoietic VME. These megakaryocytes continue to mature, penetrate the vessel wall, and release platelets into the vessel lumen. This process can be blocked with the addition of antibodies specific for CXCR4, indicating that CXCR4 is required for megakaryocyte migration, though whether it is sufficient is unclear. The 3D marrow VME system shows considerable potential for mechanistic studies defining the role of marrow vasculature in thrombopoiesis. Through a stepwise addition or removal of individual marrow components, this model provides potential to define key pathways responsible for the release of platelets and other blood cells.

Indexed as

Cellular MicroenvironmentAntibodiesAntigens, CD34Blood PlateletsBone Marrow CellsCell Culture TechniquesCell MovementCells, CulturedHumansHuman Umbilical Vein Endothelial CellsMegakaryocytesMicroscopy, ConfocalMicroscopy, ElectronMicrovesselsReceptors, CXCR4Stromal CellsAntibodiesAntigens, CD34CXCR4 protein, humanReceptors, CXCR4

Identifiers

PMID29617409
PMCPMC5884538
OpenAlexW2796339782

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.